Loading clinical trials...
Loading clinical trials...
A Phase I, Two Part Study Exploring the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effect of Ascending Doses of BL-8040 in Healthy Subjects.
Conditions
Interventions
BL-8040
Placebo
Locations
1
Israel
Hadassah Clinical Research Center
Jerusalem, Israel
Start Date
August 1, 2014
Primary Completion Date
July 1, 2015
Completion Date
July 1, 2015
Last Updated
July 31, 2015
Lead Sponsor
BioLineRx, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions